Literature DB >> 20670822

Complementary and alternative interventions in atopic dermatitis.

Joohee Lee1, Leonard Bielory.   

Abstract

The burden of atopic diseases, including atopic dermatitis (AD), is significant and far-reaching. In addition to cost of care and therapies, it affects the quality of life for those affected as well as their caretakers. Complementary and alternative therapies are commonly used because of concerns about potential adverse effects of conventional therapies and frustration with the lack of response to prescribed medications, be it due to the severity of the AD or the lack of appropriate regular use. Despite the promising results reported with various herbal medicines and biologic products, the clinical efficacy of such alternative therapies remains to be determined. Physicians need to be educated about alternative therapies and discuss benefits and potential adverse effects or limitations with patients. A systematic approach and awareness of reputable and easily accessible resources are helpful in dealing with complementary and alternative medicine (CAM). The use of CAM interventions is common among individuals with AD. Epidemiologic data have been a motivating drive for better elucidation of the efficacy of CAM interventions for allergic disease. Herbal medicines and biologics for AD treatment and, more recently, prevention comprise a major area of clinical investigation. Potential mechanisms of therapeutic effect elucidated by animal models and human clinical studies implicate modulation of TH2-type allergic inflammation and induction of immune tolerance. Population-based research regarding the use of CAM for allergic diseases underscores the increasing challenge for care providers with respect to identifying CAM use and ensuring safe use of allopathic and complementary medicines in disease management. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20670822     DOI: 10.1016/j.iac.2010.06.006

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  4 in total

1.  Hwangryunhaedoktang in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, two-centre trial--study protocol.

Authors:  Nam-Kwen Kim; Dong-Hyo Lee; Hyung-Sik Seo; Seung-Ho Sun; Yong-Leol Oh; Ji-Eun Kim; In-Hwan Yoon; Eun-Sung Seo; Gye-Seon Shim; Christopher Zaslawski
Journal:  BMC Complement Altern Med       Date:  2011-08-23       Impact factor: 3.659

2.  Coptis chinensis and Myrobalan (Terminalia chebula) Can Synergistically Inhibit Inflammatory Response In Vitro and In Vivo.

Authors:  Enhui Cui; Xiaoyan Zhi; Ying Chen; Yuanyuan Gao; Yunpeng Fan; Weimin Zhang; Wuren Ma; Weifeng Hou; Chao Guo; Xiaoping Song
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-18       Impact factor: 2.629

3.  Effect of Agrimonia pilosa Ledeb Extract on the Antinociception and Mechanisms in Mouse.

Authors:  Soo-Hyun Park; Yun-Beom Sim; Yu-Jung Kang; Jin-Koo Lee; Soon-Sung Lim; Hong-Won Suh
Journal:  Korean J Physiol Pharmacol       Date:  2012-04-24       Impact factor: 2.016

4.  In Vitro antibacterial efficacy of 21 Indian timber-yielding plants against multidrug-resistant bacteria causing urinary tract infection.

Authors:  Monali P Mishra; Rabindra N Padhy
Journal:  Osong Public Health Res Perspect       Date:  2013-11-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.